DEXTROMETHORPHAN

DEXTROMETHORPHAN was reported 21195 times

DEXTROMETHORPHAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BREAST CONSERVING SURGERY 29 0.0566
1 POSTMORTEM BLOOD DRUG LEVEL INCREASED 19 0.0509
2 OSMOLAR GAP INCREASED 4 0.0396
3 HUMAN HERPESVIRUS 6 INFECTION REACTIVATION 10 0.0285
4 NECROSIS ISCHAEMIC 12 0.0260
5 PERITONEAL PERFORATION 4 0.0242
6 FAILURE OF CHILD RESISTANT PRODUCT CLOSURE 3 0.0217
7 ANTIDEPRESSANT DRUG LEVEL ABOVE THERAPEUTIC 5 0.0193
8 CENTRAL NERVOUS SYSTEM STIMULATION 3 0.0169
9 EXPOSURE VIA INGESTION 38 0.0150
10 ANION GAP ABNORMAL 4 0.0149
11 TOXICOLOGIC TEST ABNORMAL 9 0.0149
12 ACCIDENTAL DEATH 27 0.0145
13 FACET JOINT SYNDROME 46 0.0141
14 COMPULSIVE SEXUAL BEHAVIOUR 11 0.0136
15 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 92 0.0135
16 CORYNEBACTERIUM INFECTION 7 0.0131
17 NAIL OPERATION 5 0.0121
18 ACCIDENTAL OVERDOSE 404 0.0110
19 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 79 0.0110
20 DEEP VEIN THROMBOSIS POSTOPERATIVE 22 0.0110
21 PNEUMONIA STREPTOCOCCAL 12 0.0109
22 PNEUMONIA NECROTISING 7 0.0108
23 OPIATES POSITIVE 5 0.0104
24 SUDDEN INFANT DEATH SYNDROME 5 0.0102
25 GASTROINTESTINAL MUCOSA HYPERAEMIA 3 0.0101
26 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 59 0.0097
27 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 12 0.0095
28 ECHOLALIA 3 0.0094
29 SWOLLEN JOINT COUNT INCREASED 30 0.0094
30 INFLUENZA A VIRUS TEST POSITIVE 4 0.0093
31 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 5 0.0089
32 DRUG ABUSE 723 0.0087
33 RHEUMATIC FEVER 38 0.0085
34 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 19 0.0085
35 GRANDIOSITY 3 0.0082
36 CONDUCTION DISORDER 15 0.0082
37 SEROTONIN SYNDROME 155 0.0081
38 CLONUS 22 0.0080
39 ABORTION THREATENED 4 0.0080
40 HYPERREFLEXIA 28 0.0080
41 OBSTRUCTION 32 0.0080
42 HYPERLEUKOCYTOSIS 7 0.0079
43 PERIPHERAL VENOUS DISEASE 32 0.0078
44 HYPERCHLORAEMIA 5 0.0078
45 HOMICIDE 14 0.0076
46 ALBUMINURIA 4 0.0075
47 AUTOSCOPY 4 0.0074
48 C-REACTIVE PROTEIN ABNORMAL 47 0.0073
49 CYTOKINE STORM 5 0.0073
50 SUSPECTED SUICIDE 34 0.0072
51 STRESS AT WORK 8 0.0071
52 HALLUCINATION, OLFACTORY 3 0.0069
53 GASTROINTESTINAL MUCOSAL DISORDER 4 0.0061
54 ONYCHOMADESIS 25 0.0060
55 SUBSTANCE DEPENDENCE 4 0.0059
56 LEFT VENTRICULAR DILATATION 3 0.0059
57 LOWER RESPIRATORY TRACT INFECTION BACTERIAL 3 0.0059
58 ACCIDENTAL POISONING 8 0.0058
59 MYDRIASIS 73 0.0057
60 POISONING 71 0.0056
61 DUODENAL ULCER PERFORATION 42 0.0056
62 DISSOCIATIVE DISORDER 4 0.0055
63 FEELING DRUNK 41 0.0055
64 SLOW RESPONSE TO STIMULI 7 0.0054
65 FINGER DEFORMITY 26 0.0054
66 TRACHEITIS 4 0.0052
67 MOTOR DEVELOPMENTAL DELAY 3 0.0052
68 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 37 0.0052
69 HYPORESPONSIVE TO STIMULI 6 0.0051
70 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 26 0.0051
71 ONYCHOMYCOSIS 22 0.0050
72 TOXIC ENCEPHALOPATHY 25 0.0049
73 ANION GAP 3 0.0047
74 RHEUMATOID FACTOR POSITIVE 27 0.0047
75 ACCIDENTAL DRUG INTAKE BY CHILD 7 0.0046
76 NEPHROSCLEROSIS 5 0.0045
77 CARDIAC HYPERTROPHY 5 0.0045
78 X-RAY ABNORMAL 8 0.0045
79 BRADYPNOEA 12 0.0044
80 IMMUNE THROMBOCYTOPENIA 20 0.0044
81 PSYCHOTIC SYMPTOM 9 0.0044
82 COMPLETED SUICIDE 352 0.0042
83 LABELLED DRUG-DRUG INTERACTION ISSUE 6 0.0041
84 RESPIRATORY RATE DECREASED 13 0.0041
85 TOXICITY TO VARIOUS AGENTS 693 0.0041
86 EUPHORIC MOOD 42 0.0041
87 HELICOBACTER INFECTION 42 0.0041
88 EXPOSURE TO TOXIC AGENT 13 0.0041
89 AMPHETAMINES POSITIVE 3 0.0040
90 LOGORRHOEA 14 0.0040
91 CONTRAINDICATION TO MEDICAL TREATMENT 6 0.0039
92 FOLLICULITIS 41 0.0039
93 QUADRIPLEGIA 8 0.0039
94 BURSITIS 47 0.0039
95 ALVEOLITIS ALLERGIC 4 0.0039
96 MUSCLE INJURY 32 0.0039
97 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 8 0.0039
98 LABORATORY TEST INTERFERENCE 3 0.0038
99 BLEPHAROSPASM 24 0.0038
100 EYELID FUNCTION DISORDER 3 0.0038
101 PUPILLARY REFLEX IMPAIRED 7 0.0038
102 PRODUCT LABEL CONFUSION 22 0.0038
103 DRUG TOXICITY 51 0.0037
104 LIP DRY 34 0.0037
105 ANION GAP INCREASED 5 0.0037
106 HEAD TITUBATION 5 0.0036
107 KLEBSIELLA SEPSIS 4 0.0035
108 DISLOCATION OF VERTEBRA 8 0.0035
109 CARDIO-RESPIRATORY ARREST 145 0.0035
110 MATERNAL EXPOSURE TIMING UNSPECIFIED 13 0.0035
111 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 22 0.0034
112 DRUG WITHDRAWAL CONVULSIONS 6 0.0034
113 RESPIRATORY ARREST 92 0.0033
114 SUPERINFECTION 5 0.0033
115 PNEUMONIA PSEUDOMONAL 5 0.0033
116 BREAST CANCER STAGE III 21 0.0032
117 INAPPROPRIATE AFFECT 5 0.0032
118 HANGOVER 11 0.0031
119 IMMUNE RECONSTITUTION SYNDROME 4 0.0031
120 HYPERTHERMIA 23 0.0030
121 GLYCOSURIA 4 0.0030
122 PEMPHIGUS 37 0.0030
123 RESPIRATORY DEPRESSION 36 0.0029
124 BRONCHOPNEUMONIA 10 0.0029
125 DRUG SCREEN POSITIVE 23 0.0029
126 INTENTIONAL OVERDOSE 184 0.0029
127 NAIL DISORDER 25 0.0029
128 EOSINOPHILIA 50 0.0029
129 GRIP STRENGTH DECREASED 25 0.0028
130 FULL BLOOD COUNT ABNORMAL 30 0.0028
131 HAND DEFORMITY 37 0.0028
132 OVERDOSE 599 0.0028
133 AORTIC ARTERIOSCLEROSIS 7 0.0027
134 PARADOXICAL DRUG REACTION 10 0.0027
135 INFUSION SITE REACTION 8 0.0027
136 HYPERTENSIVE HEART DISEASE 5 0.0027
137 COELIAC DISEASE 26 0.0026
138 MOANING 3 0.0026
139 EYE INJURY 8 0.0026
140 LICHENOID KERATOSIS 6 0.0026
141 MIOSIS 21 0.0026
142 BACK INJURY 28 0.0026
143 SKIN ABRASION 12 0.0025
144 JOINT RANGE OF MOTION DECREASED 34 0.0025
145 LIVER INJURY 62 0.0025
146 MYOPIA 6 0.0025
147 STARING 6 0.0025
148 INCOHERENT 16 0.0025
149 AUTOIMMUNE DISORDER 24 0.0025
150 LUPUS VULGARIS 3 0.0024
151 PULMONARY CONGESTION 31 0.0023
152 PSYCHOMOTOR HYPERACTIVITY 39 0.0023
153 OBESITY 37 0.0023
154 PSEUDOMONAL SEPSIS 4 0.0023
155 RETROPERITONEAL HAEMATOMA 5 0.0023
156 AREFLEXIA 6 0.0022
157 NON-CARDIAC CHEST PAIN 7 0.0022
158 PERICARDITIS 37 0.0022
159 CARBON DIOXIDE INCREASED 3 0.0022
160 INFUSION SITE RASH 3 0.0022
161 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 37 0.0022
162 HYPERCHOLESTEROLAEMIA 21 0.0022
163 SINUS DISORDER 43 0.0022
164 DRUG USE DISORDER 18 0.0021
165 DRUG ABUSER 13 0.0021
166 FIBROMYALGIA 51 0.0021
167 SYNOVITIS 37 0.0020
168 ABDOMINAL WALL HAEMATOMA 4 0.0020
169 LIVE BIRTH 17 0.0020
170 GASTRITIS HAEMORRHAGIC 3 0.0020
171 GASTROINTESTINAL WALL THICKENING 3 0.0020
172 MUCOSAL DRYNESS 4 0.0020
173 FOAMING AT MOUTH 4 0.0020
174 EAR HAEMORRHAGE 4 0.0020
175 INJECTION SITE NECROSIS 4 0.0020
176 ADVERSE REACTION 26 0.0020
177 SELF-MEDICATION 8 0.0019
178 MYOCLONUS 23 0.0019
179 WOUND INFECTION 21 0.0019
180 UNRESPONSIVE TO STIMULI 49 0.0019
181 ANTICHOLINERGIC SYNDROME 3 0.0019
182 PNEUMONIA VIRAL 6 0.0019
183 IRRITABLE BOWEL SYNDROME 40 0.0019
184 SUBSTANCE ABUSE 15 0.0018
185 GLOSSODYNIA 41 0.0018
186 PRODUCT LOT NUMBER ISSUE 4 0.0018
187 ATAXIA 21 0.0018
188 LAZINESS 3 0.0018
189 OESOPHAGEAL CANDIDIASIS 7 0.0018
190 PUSTULAR PSORIASIS 6 0.0017
191 FIXED ERUPTION 3 0.0017
192 ACUTE SINUSITIS 3 0.0017
193 HYPERTONIC BLADDER 5 0.0017
194 INTENTIONAL DRUG MISUSE 36 0.0017
195 INFUSION SITE DISCHARGE 3 0.0017
196 PRODUCT TASTE ABNORMAL 23 0.0017
197 NYSTAGMUS 9 0.0017
198 CONTRAINDICATED PRODUCT ADMINISTERED 51 0.0017
199 GAIT INABILITY 56 0.0017
200 INCORRECT PRODUCT ADMINISTRATION DURATION 36 0.0017
201 ARTERIOSCLEROSIS CORONARY ARTERY 11 0.0017
202 COMA 79 0.0017
203 EXPIRED PRODUCT ADMINISTERED 55 0.0017
204 DEPRESSED LEVEL OF CONSCIOUSNESS 65 0.0016
205 VENTRICULAR ARRHYTHMIA 6 0.0016
206 INCORRECT DRUG ADMINISTRATION DURATION 46 0.0016
207 HALLUCINATION 123 0.0016
208 DISORGANISED SPEECH 3 0.0016
209 MENISCUS INJURY 10 0.0016
210 SMALL FOR DATES BABY 8 0.0016
211 ABDOMINAL TENDERNESS 8 0.0016
212 PERSECUTORY DELUSION 4 0.0016
213 LEUKOCYTOSIS 29 0.0016
214 DERMATITIS EXFOLIATIVE 8 0.0016
215 PRODUCTIVE COUGH 76 0.0016
216 HYPERTRANSAMINASAEMIA 11 0.0016
217 RESPIRATORY RATE INCREASED 14 0.0016
218 DRUG LEVEL INCREASED 26 0.0016
219 SUBSTANCE USE DISORDER 5 0.0016
220 WHEEZING 93 0.0016
221 MENTAL IMPAIRMENT 38 0.0016
222 HYPOREFLEXIA 3 0.0016
223 IRON DEFICIENCY 7 0.0016
224 STUPOR 5 0.0016
225 THERAPEUTIC PRODUCT INEFFECTIVE 6 0.0016
226 CONVERSION DISORDER 3 0.0015
227 ALCOHOL INTERACTION 3 0.0015
228 RESPIRATORY DISORDER 46 0.0015
229 AGITATION 112 0.0015
230 CATATONIA 8 0.0015
231 HALLUCINATION, VISUAL 32 0.0015
232 PARANOIA 26 0.0015
233 POTENTIATING DRUG INTERACTION 5 0.0015
234 PNEUMONIA ASPIRATION 37 0.0015
235 CHEILITIS 8 0.0015
236 ULCER HAEMORRHAGE 10 0.0015
237 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 13 0.0015
238 WOUND 41 0.0015
239 DRUG INTERACTION 232 0.0015
240 ASPIRATION 16 0.0015
241 JOINT EFFUSION 10 0.0014
242 SOCIAL PROBLEM 6 0.0014
243 PLEURITIC PAIN 4 0.0014
244 JOINT DISLOCATION 15 0.0014
245 GASTROINTESTINAL SOUNDS ABNORMAL 7 0.0014
246 DELIRIUM 49 0.0014
247 TYPE 2 DIABETES MELLITUS 47 0.0014
248 INFUSION SITE BRUISING 3 0.0014
249 FACIAL BONES FRACTURE 5 0.0014
250 DRUG TOLERANCE 7 0.0014
251 IMPAIRED HEALING 45 0.0014
252 NO ADVERSE EVENT 248 0.0014
253 MAJOR DEPRESSION 10 0.0014
254 BIPOLAR I DISORDER 3 0.0014
255 INITIAL INSOMNIA 14 0.0014
256 CLOSTRIDIUM TEST POSITIVE 3 0.0014
257 CARDIAC ARREST 112 0.0014
258 LIVER FUNCTION TEST INCREASED 29 0.0013
259 NEUROLEPTIC MALIGNANT SYNDROME 16 0.0013
260 FAILURE TO THRIVE 7 0.0013
261 WRONG DRUG ADMINISTERED 12 0.0013
262 ATELECTASIS 13 0.0013
263 POLYURIA 11 0.0013
264 DISORIENTATION 53 0.0013
265 MENTAL STATUS CHANGES 37 0.0013
266 COMMUNICATION DISORDER 5 0.0013
267 SLEEP DISORDER 91 0.0013
268 SUICIDE ATTEMPT 78 0.0013
269 CARDIOPULMONARY FAILURE 5 0.0013
270 METABOLIC ACIDOSIS 41 0.0013
271 INGROWING NAIL 3 0.0013
272 SINUS TACHYCARDIA 18 0.0013
273 POISONING DELIBERATE 12 0.0013
274 NECROSIS 7 0.0013
275 SCIATICA 20 0.0013
276 DRUG-INDUCED LIVER INJURY 39 0.0012
277 TASTE DISORDER 25 0.0012
278 RASH MACULO-PAPULAR 27 0.0012
279 PRODUCT FORMULATION ISSUE 8 0.0012
280 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 58 0.0012
281 ELECTROLYTE IMBALANCE 14 0.0012
282 ANXIETY DISORDER 4 0.0012
283 HYPERPARATHYROIDISM SECONDARY 3 0.0012
284 BRAIN OEDEMA 15 0.0012
285 SUDDEN CARDIAC DEATH 4 0.0012
286 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 61 0.0012
287 EYE MOVEMENT DISORDER 8 0.0012
288 MENTAL DISORDER 50 0.0011
289 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 3 0.0011
290 SEASONAL ALLERGY 16 0.0011
291 SYSTEMIC LUPUS ERYTHEMATOSUS 40 0.0011
292 TACHYCARDIA 100 0.0011
293 ALCOHOL POISONING 3 0.0011
294 ABDOMINAL MASS 3 0.0011
295 COUGH 313 0.0011
296 EAR CONGESTION 3 0.0011
297 NORMAL NEWBORN 6 0.0011
298 SCLERODERMA 4 0.0011
299 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 78 0.0011
300 DRUG LEVEL ABOVE THERAPEUTIC 5 0.0011
301 THERAPY NON-RESPONDER 49 0.0011
302 CHOKING SENSATION 6 0.0011
303 ABNORMAL BEHAVIOUR 43 0.0011
304 COAGULOPATHY 18 0.0011
305 LEUKOENCEPHALOPATHY 4 0.0011
306 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 31 0.0011
307 CARDIOMEGALY 13 0.0011
308 VIRAL UPPER RESPIRATORY TRACT INFECTION 5 0.0011
309 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 18 0.0010
310 PSYCHOTIC DISORDER 31 0.0010
311 FEELING JITTERY 20 0.0010
312 DYSARTHRIA 39 0.0010
313 ESCHERICHIA SEPSIS 3 0.0010
314 RASH VESICULAR 5 0.0010
315 SOMNOLENCE 208 0.0010
316 AUTONOMIC NERVOUS SYSTEM IMBALANCE 3 0.0010
317 NIGHT SWEATS 33 0.0010
318 RENAL CELL CARCINOMA 5 0.0010
319 ENERGY INCREASED 6 0.0010
320 HEPATITIS 26 0.0010
321 ALTERED STATE OF CONSCIOUSNESS 22 0.0010
322 PNEUMONIA FUNGAL 4 0.0010
323 RESTLESSNESS 37 0.0010
324 ARTHROPATHY 56 0.0010
325 NASAL CONGESTION 59 0.0010
326 DRUG INEFFECTIVE 1323 0.0010
327 ATRIAL FLUTTER 8 0.0010
328 AGGRESSION 50 0.0010
329 DISSEMINATED INTRAVASCULAR COAGULATION 14 0.0010
330 LOWER LIMB FRACTURE 19 0.0010
331 BLOOD CHOLESTEROL INCREASED 46 0.0010
332 INTENTIONAL PRODUCT MISUSE 86 0.0010
333 BLISTER 55 0.0010
334 ANAPHYLACTOID REACTION 4 0.0010
335 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 6 0.0010
336 BRAIN DEATH 3 0.0010
337 ERYTHEMA MULTIFORME 9 0.0010
338 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 68 0.0010
339 HALLUCINATIONS, MIXED 4 0.0010
340 INFUSION SITE PRURITUS 3 0.0009
341 SUDDEN DEATH 10 0.0009
342 HEPATOTOXICITY 21 0.0009
343 LOSS OF THERAPEUTIC RESPONSE 3 0.0009
344 ATRIOVENTRICULAR BLOCK FIRST DEGREE 4 0.0009
345 LETHARGY 53 0.0009
346 SINUSITIS 94 0.0009
347 PULMONARY OEDEMA 41 0.0009
348 DIZZINESS 455 0.0009
349 DYSPHEMIA 4 0.0009
350 INFUSION SITE HAEMORRHAGE 3 0.0009
351 PSORIATIC ARTHROPATHY 37 0.0009
352 HEPATIC CIRRHOSIS 17 0.0009
353 CONFUSIONAL STATE 146 0.0009
354 DRY MOUTH 73 0.0009
355 INFLAMMATION 46 0.0009
356 RHABDOMYOLYSIS 37 0.0009
357 DRY THROAT 9 0.0009
358 PRODUCT LABEL ISSUE 6 0.0009
359 PRODUCT COMPLAINT 22 0.0009
360 VENTRICULAR EXTRASYSTOLES 9 0.0009
361 NEPHROGENIC ANAEMIA 4 0.0009
362 ELECTROCARDIOGRAM QT PROLONGED 31 0.0009
363 HEPATIC STEATOSIS 16 0.0009
364 LOWER RESPIRATORY TRACT INFECTION 39 0.0009
365 EPILEPSY 26 0.0008
366 SPUTUM DISCOLOURED 8 0.0008
367 STOMATITIS 51 0.0008
368 SUBDURAL HAEMATOMA 12 0.0008
369 LUNG DISORDER 41 0.0008
370 TREMOR 137 0.0008
371 RHINORRHOEA 53 0.0008
372 ALCOHOL USE 3 0.0008
373 CARDIAC DYSFUNCTION 3 0.0008
374 AKATHISIA 11 0.0008
375 MULTIPLE DRUG OVERDOSE 4 0.0008
376 OSTEOARTHRITIS 34 0.0008
377 HYPERAMMONAEMIA 4 0.0008
378 STATUS EPILEPTICUS 9 0.0008
379 HYPOAESTHESIA ORAL 12 0.0008
380 INSOMNIA 211 0.0008
381 INTENTIONAL SELF-INJURY 16 0.0008
382 IMPAIRED DRIVING ABILITY 9 0.0008
383 MANIA 13 0.0008
384 TROPONIN INCREASED 6 0.0008
385 GENERALISED TONIC-CLONIC SEIZURE 13 0.0008
386 SCREAMING 5 0.0008
387 CARDIOTOXICITY 7 0.0008
388 INFUSION RELATED REACTION 52 0.0008
389 DISSOCIATION 6 0.0008
390 UPPER RESPIRATORY TRACT INFECTION 36 0.0008
391 LOSS OF LIBIDO 7 0.0008
392 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 20 0.0008
393 ENCEPHALOPATHY 19 0.0008
394 LUPUS-LIKE SYNDROME 7 0.0008
395 BRONCHOSPASM 11 0.0008
396 PRODUCT ADMINISTRATION INTERRUPTED 6 0.0008
397 MUSCULOSKELETAL PAIN 40 0.0008
398 ASPERGILLUS INFECTION 5 0.0008
399 WALKING AID USER 5 0.0008
400 ILL-DEFINED DISORDER 46 0.0008
401 INJURY 53 0.0008
402 ENURESIS 3 0.0007
403 NEUROTOXICITY 13 0.0007
404 STRESS FRACTURE 4 0.0007
405 SINUS CONGESTION 10 0.0007
406 SHOCK HAEMORRHAGIC 6 0.0007
407 BIPOLAR DISORDER 8 0.0007
408 TACHYPNOEA 10 0.0007
409 RESPIRATION ABNORMAL 5 0.0007
410 PRESCRIBED OVERDOSE 14 0.0007
411 DYSTONIA 14 0.0007
412 STREPTOCOCCAL INFECTION 4 0.0007
413 ABDOMINAL PAIN UPPER 148 0.0007
414 VITAMIN D DEFICIENCY 7 0.0007
415 HEART RATE ABNORMAL 4 0.0007
416 THERAPEUTIC PRODUCT EFFECT DECREASED 32 0.0007
417 SEPTIC SHOCK 31 0.0007
418 HYPOXIA 25 0.0007
419 DELUSION 11 0.0007
420 ASTHMA 80 0.0007
421 CARDIAC FAILURE CHRONIC 3 0.0007
422 RETCHING 15 0.0007
423 FEELING ABNORMAL 168 0.0007
424 PSEUDOMONAS INFECTION 6 0.0007
425 HYPERTONIA 4 0.0007
426 BRAIN INJURY 7 0.0007
427 LOSS OF CONSCIOUSNESS 89 0.0007
428 EMPHYSEMA 7 0.0007
429 ROAD TRAFFIC ACCIDENT 29 0.0007
430 HYPERVENTILATION 4 0.0007
431 HYPOAESTHESIA 103 0.0007
432 C-REACTIVE PROTEIN INCREASED 25 0.0007
433 HYPERGLYCAEMIA 25 0.0007
434 HYPOVOLAEMIA 4 0.0007
435 GASTROINTESTINAL DISORDER 61 0.0007
436 PULMONARY FIBROSIS 13 0.0007
437 ACUTE RESPIRATORY FAILURE 13 0.0007
438 CHEST DISCOMFORT 69 0.0007
439 PLEURISY 4 0.0007
440 MUSCLE RIGIDITY 8 0.0007
441 GENERAL SYMPTOM 5 0.0007
442 TYPE 1 DIABETES MELLITUS 4 0.0007
443 NECK PAIN 37 0.0007
444 HEPATIC ENZYME INCREASED 45 0.0007
445 EXPOSURE DURING PREGNANCY 41 0.0007
446 OSTEOPENIA 10 0.0007
447 END STAGE RENAL DISEASE 12 0.0007
448 EXOSTOSIS 6 0.0007
449 HIP ARTHROPLASTY 10 0.0007
450 HYPERTENSION 138 0.0007
451 FEBRILE NEUTROPENIA 43 0.0006
452 PHARYNGITIS 8 0.0006
453 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 5 0.0006
454 FEELING OF DESPAIR 3 0.0006
455 CARPAL TUNNEL SYNDROME 9 0.0006
456 DIARRHOEA 414 0.0006
457 TUBULOINTERSTITIAL NEPHRITIS 12 0.0006
458 NASAL DRYNESS 4 0.0006
459 MULTIPLE ALLERGIES 5 0.0006
460 INFUSION SITE SWELLING 4 0.0006
461 PNEUMONIA 205 0.0006
462 RED BLOOD CELL SEDIMENTATION RATE INCREASED 7 0.0006
463 ANXIETY 180 0.0006
464 SWELLING 59 0.0006
465 HALLUCINATION, AUDITORY 10 0.0006
466 HYPOTHYROIDISM 20 0.0006
467 FAECAL INCONTINENCE 3 0.0006
468 PARAESTHESIA ORAL 9 0.0006
469 MITRAL VALVE INCOMPETENCE 7 0.0006
470 HEART RATE INCREASED 61 0.0006
471 CONTUSION 59 0.0006
472 NERVOUSNESS 32 0.0006
473 MEDICATION ERROR 34 0.0006
474 HAEMOPTYSIS 17 0.0006
475 GASTROOESOPHAGEAL REFLUX DISEASE 49 0.0006
476 ABDOMINAL DISCOMFORT 102 0.0006
477 HYPOTONIA 6 0.0006
478 CHOLECYSTITIS CHRONIC 4 0.0006
479 LEFT VENTRICULAR DYSFUNCTION 4 0.0006
480 CORONARY ARTERY DISEASE 18 0.0006
481 COLITIS ISCHAEMIC 4 0.0006
482 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 3 0.0006
483 WRONG PRODUCT ADMINISTERED 4 0.0006
484 THROAT TIGHTNESS 16 0.0006
485 DRUG INTOLERANCE 57 0.0006
486 DISCOMFORT 36 0.0006
487 DYSPEPSIA 58 0.0006
488 NASOPHARYNGITIS 108 0.0006
489 MOBILITY DECREASED 42 0.0006
490 INCREASED UPPER AIRWAY SECRETION 3 0.0006
491 CACHEXIA 3 0.0006
492 URTICARIA 97 0.0006
493 DIPLOPIA 15 0.0006
494 PYELONEPHRITIS 5 0.0006
495 SLEEP APNOEA SYNDROME 11 0.0006
496 RESPIRATORY TRACT INFECTION 15 0.0006
497 HYPERHIDROSIS 74 0.0006
498 WEIGHT FLUCTUATION 6 0.0006
499 SEDATION 15 0.0006
500 MUSCULOSKELETAL STIFFNESS 50 0.0006
501 BLOOD LACTIC ACID INCREASED 3 0.0006
502 INCONTINENCE 6 0.0006
503 COLD SWEAT 10 0.0006
504 CONDITION AGGRAVATED 172 0.0006
505 LYMPHOPENIA 8 0.0006
506 IRRITABILITY 34 0.0006
507 HEAD DISCOMFORT 10 0.0006
508 FOOD POISONING 3 0.0006
509 SECRETION DISCHARGE 7 0.0006
510 MYOSITIS 5 0.0006
511 BRUXISM 3 0.0006
512 FEELING HOT 34 0.0006
513 TOOTHACHE 10 0.0006
514 HYDROCEPHALUS 3 0.0006
515 RESTLESS LEGS SYNDROME 10 0.0005
516 BLOOD PRESSURE INCREASED 84 0.0005
517 PREGNANCY 11 0.0005
518 LIQUID PRODUCT PHYSICAL ISSUE 4 0.0005
519 DYSSTASIA 16 0.0005
520 MOUTH HAEMORRHAGE 4 0.0005
521 INTESTINAL ISCHAEMIA 3 0.0005
522 HYPERSENSITIVITY 101 0.0005
523 INFUSION SITE PAIN 7 0.0005
524 HIATUS HERNIA 7 0.0005
525 INTERVERTEBRAL DISC DEGENERATION 5 0.0005
526 BLOOD UREA INCREASED 9 0.0005
527 THINKING ABNORMAL 10 0.0005
528 INTENTIONAL PRODUCT USE ISSUE 47 0.0005
529 ANGIOPATHY 3 0.0005
530 OEDEMA 29 0.0005
531 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 96 0.0005
532 REBOUND EFFECT 6 0.0005
533 UNEVALUABLE EVENT 40 0.0005
534 RESPIRATORY FAILURE 38 0.0005
535 LIVER DISORDER 23 0.0005
536 VOMITING 243 0.0005
537 BRONCHOPULMONARY ASPERGILLOSIS 4 0.0005
538 EAR PAIN 10 0.0005
539 PNEUMONITIS 14 0.0005
540 THERAPEUTIC RESPONSE UNEXPECTED 23 0.0005
541 FEELING OF BODY TEMPERATURE CHANGE 3 0.0005
542 LIP SWELLING 17 0.0005
543 BRAIN FOG 8 0.0005
544 TORSADE DE POINTES 4 0.0005
545 RENAL TUBULAR NECROSIS 5 0.0005
546 AFFECTIVE DISORDER 4 0.0005
547 BODY TEMPERATURE DECREASED 5 0.0005
548 RESPIRATORY DISTRESS 14 0.0005
549 RESPIRATORY TRACT CONGESTION 8 0.0005
550 HYPOMAGNESAEMIA 7 0.0005
551 ACCIDENT 6 0.0005
552 BRONCHITIS 37 0.0005
553 SKIN REACTION 7 0.0005
554 EXTRA DOSE ADMINISTERED 20 0.0005
555 INGUINAL HERNIA 3 0.0005
556 DECUBITUS ULCER 4 0.0005
557 PANCREATITIS ACUTE 11 0.0005
558 BREAST CANCER STAGE II 4 0.0005
559 PULMONARY HYPERTENSION 10 0.0005
560 DEPRESSION 109 0.0005
561 PHOTOPHOBIA 9 0.0005
562 SPEECH DISORDER 25 0.0005
563 WITHDRAWAL SYNDROME 20 0.0005
564 GENERAL PHYSICAL HEALTH DETERIORATION 55 0.0005
565 KNEE ARTHROPLASTY 10 0.0005
566 INFUSION SITE ERYTHEMA 4 0.0005
567 GASTRIC ULCER 9 0.0005
568 URINARY INCONTINENCE 14 0.0005
569 JOINT SWELLING 57 0.0005
570 PRODUCT USE IN UNAPPROVED INDICATION 115 0.0005
571 DECREASED ACTIVITY 5 0.0005
572 LACTIC ACIDOSIS 15 0.0005
573 BLOOD COUNT ABNORMAL 7 0.0005
574 FAECES DISCOLOURED 10 0.0005
575 SKIN LACERATION 5 0.0005
576 ORTHOSTATIC HYPOTENSION 8 0.0005
577 INSURANCE ISSUE 7 0.0005
578 EYE SWELLING 17 0.0005
579 EYE DISORDER 15 0.0005
580 SPINAL OSTEOARTHRITIS 4 0.0005
581 DISABILITY 9 0.0005
582 VISION BLURRED 62 0.0005
583 PARAESTHESIA 71 0.0005
584 FOOT DEFORMITY 5 0.0005
585 VIRAL INFECTION 15 0.0005
586 DYSPNOEA 255 0.0005
587 MENINGITIS 3 0.0004
588 SKIN INFECTION 5 0.0004
589 ANAL INCONTINENCE 4 0.0004
590 CHROMATURIA 10 0.0004
591 EYE INFECTION 5 0.0004
592 PNEUMOTHORAX 7 0.0004
593 BODY TEMPERATURE INCREASED 9 0.0004
594 ABNORMAL LOSS OF WEIGHT 3 0.0004
595 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 24 0.0004
596 PNEUMONIA BACTERIAL 4 0.0004
597 INCREASED TENDENCY TO BRUISE 4 0.0004
598 DYSURIA 16 0.0004
599 DROOLING 3 0.0004
600 LYMPHOEDEMA 3 0.0004
601 AUTOIMMUNE HEPATITIS 3 0.0004
602 FEELING COLD 12 0.0004
603 BACK DISORDER 7 0.0004
604 AMNESIA 28 0.0004
605 COORDINATION ABNORMAL 6 0.0004
606 APHONIA 6 0.0004
607 EXTRASYSTOLES 3 0.0004
608 PYREXIA 148 0.0004
609 DYSPNOEA EXERTIONAL 16 0.0004
610 BLOOD SODIUM DECREASED 8 0.0004
611 THROAT IRRITATION 19 0.0004
612 RHEUMATOID ARTHRITIS 48 0.0004
613 ABDOMINAL DISTENSION 44 0.0004
614 BACTERAEMIA 5 0.0004
615 INTERNATIONAL NORMALISED RATIO INCREASED 12 0.0004
616 DISEASE RECURRENCE 20 0.0004
617 CHOLECYSTITIS 5 0.0004
618 HYPOTENSION 84 0.0004
619 DYSKINESIA 17 0.0004
620 ACUTE KIDNEY INJURY 64 0.0004
621 GAIT DISTURBANCE 80 0.0004
622 IMPAIRED QUALITY OF LIFE 6 0.0004
623 CELLULITIS 21 0.0004
624 PRODUCT USE ISSUE 78 0.0004
625 ANOSMIA 6 0.0004
626 NOCTURIA 5 0.0004
627 TREATMENT FAILURE 34 0.0004
628 DISTURBANCE IN ATTENTION 22 0.0004
629 ASTHENIA 153 0.0004
630 MALAISE 178 0.0004
631 ARTHROPOD BITE 3 0.0004
632 TRANSAMINASES INCREASED 9 0.0004
633 PALLOR 11 0.0004
634 ABDOMINAL PAIN 94 0.0004
635 PULMONARY MASS 6 0.0004
636 BLOOD PRESSURE ABNORMAL 8 0.0004
637 DECREASED APPETITE 93 0.0004
638 BLOOD POTASSIUM DECREASED 12 0.0004
639 PNEUMOCYSTIS JIROVECII PNEUMONIA 4 0.0004
640 BRADYCARDIA 21 0.0004
641 HYPOTHERMIA 4 0.0004
642 TOOTH ABSCESS 4 0.0004
643 PALPITATIONS 46 0.0004
644 ACIDOSIS 3 0.0004
645 INJECTION SITE REACTION 27 0.0004
646 PERIPHERAL SWELLING 60 0.0004
647 GASTROENTERITIS VIRAL 7 0.0004
648 MUSCULOSKELETAL CHEST PAIN 6 0.0004
649 CONGENITAL ANOMALY 3 0.0004
650 OEDEMA PERIPHERAL 47 0.0004
651 DEATH 332 0.0004
652 APNOEA 3 0.0004
653 EYE DISCHARGE 4 0.0004
654 THERAPY PARTIAL RESPONDER 6 0.0004
655 SWOLLEN TONGUE 12 0.0004
656 PANIC ATTACK 14 0.0004
657 WEIGHT INCREASED 86 0.0004
658 TENDERNESS 4 0.0004
659 CHEST PAIN 71 0.0004
660 CHRONIC KIDNEY DISEASE 29 0.0004
661 MATERNAL EXPOSURE DURING PREGNANCY 34 0.0004
662 MUSCLE SPASMS 70 0.0004
663 PRODUCT USE COMPLAINT 6 0.0004
664 TOOTH INFECTION 5 0.0004
665 SCRATCH 4 0.0004
666 FURUNCLE 3 0.0004
667 MIGRAINE 36 0.0004
668 GINGIVAL PAIN 3 0.0004
669 HEADACHE 236 0.0004
670 BLOOD PRESSURE DECREASED 25 0.0004
671 EATING DISORDER 8 0.0004
672 OXYGEN SATURATION DECREASED 21 0.0004
673 NAUSEA 293 0.0004
674 ASPHYXIA 3 0.0004
675 OROPHARYNGEAL PAIN 34 0.0004
676 CONVULSION 21 0.0004
677 ABNORMAL FAECES 3 0.0004
678 OESOPHAGITIS 4 0.0004
679 HYPERAESTHESIA 3 0.0004
680 HEPATIC FAILURE 11 0.0004
681 COVID-19 64 0.0004
682 OSTEOPOROSIS 15 0.0004
683 BLOOD ALKALINE PHOSPHATASE INCREASED 9 0.0004
684 STEVENS-JOHNSON SYNDROME 8 0.0004
685 SYNCOPE 36 0.0004
686 ATRIAL FIBRILLATION 35 0.0004
687 PANCYTOPENIA 20 0.0004
688 MALNUTRITION 4 0.0004
689 SNEEZING 8 0.0004
690 OCULAR DISCOMFORT 4 0.0004
691 BREAST CANCER 33 0.0004
692 HEART RATE IRREGULAR 8 0.0004
693 INADEQUATE ANALGESIA 3 0.0004
694 CIRCULATORY COLLAPSE 6 0.0004
695 MYOCARDIAL ISCHAEMIA 4 0.0004
696 PRESCRIBED UNDERDOSE 7 0.0004
697 SHOCK 8 0.0003
698 MUSCLE TWITCHING 8 0.0003
699 INFECTION 50 0.0003
700 ADVERSE DRUG REACTION 31 0.0003
701 ANAPHYLACTIC REACTION 19 0.0003
702 ALANINE AMINOTRANSFERASE INCREASED 21 0.0003
703 GROIN PAIN 3 0.0003
704 IMMUNOSUPPRESSION 3 0.0003
705 COVID-19 PNEUMONIA 4 0.0003
706 FACIAL PAIN 3 0.0003
707 BALANCE DISORDER 29 0.0003
708 IMMUNODEFICIENCY 5 0.0003
709 HAEMORRHAGE INTRACRANIAL 5 0.0003
710 FLUID RETENTION 17 0.0003
711 NEURALGIA 8 0.0003
712 CYTOPENIA 4 0.0003
713 POOR QUALITY SLEEP 7 0.0003
714 PHARYNGEAL OEDEMA 5 0.0003
715 GRAND MAL CONVULSION 3 0.0003
716 SEPSIS 36 0.0003
717 EXTRAPYRAMIDAL DISORDER 8 0.0003
718 DIARRHOEA HAEMORRHAGIC 3 0.0003
719 SEIZURE 37 0.0003
720 ASPARTATE AMINOTRANSFERASE INCREASED 17 0.0003
721 LACERATION 3 0.0003
722 ARTERIOSCLEROSIS 3 0.0003
723 FATIGUE 247 0.0003
724 MUSCULAR WEAKNESS 36 0.0003
725 HEAD INJURY 10 0.0003
726 INTENTIONAL DOSE OMISSION 9 0.0003
727 HYPERKALAEMIA 11 0.0003
728 MEMORY IMPAIRMENT 43 0.0003
729 PRURITUS 120 0.0003
730 VERTIGO 19 0.0003
731 ANOREXIA 4 0.0003
732 DIZZINESS POSTURAL 3 0.0003
733 HYPOGLYCAEMIA 15 0.0003
734 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
735 TINNITUS 14 0.0003
736 ANHEDONIA 8 0.0003
737 HOSPICE CARE 3 0.0003
738 IMMUNE SYSTEM DISORDER 4 0.0003
739 SARS-COV-2 TEST POSITIVE 4 0.0003
740 PERICARDIAL EFFUSION 7 0.0003
741 CONSTIPATION 66 0.0003
742 BLADDER DISORDER 3 0.0003
743 EAR INFECTION 8 0.0003
744 DEHYDRATION 40 0.0003
745 CYTOKINE RELEASE SYNDROME 6 0.0003
746 QUALITY OF LIFE DECREASED 4 0.0003
747 FALL 99 0.0003
748 FREQUENT BOWEL MOVEMENTS 8 0.0003
749 CANDIDA INFECTION 5 0.0003
750 INFLUENZA 33 0.0003
751 ARRHYTHMIA 14 0.0003
752 EPISTAXIS 22 0.0003
753 DRUG ADMINISTRATION ERROR 9 0.0003
754 ACUTE HEPATIC FAILURE 4 0.0003
755 TREATMENT NONCOMPLIANCE 16 0.0003
756 EAR DISCOMFORT 3 0.0003
757 CORONARY ARTERY OCCLUSION 4 0.0003
758 MUSCULOSKELETAL DISCOMFORT 5 0.0003
759 NIGHTMARE 10 0.0003
760 PRESYNCOPE 7 0.0003
761 POLLAKIURIA 12 0.0003
762 UNDERDOSE 21 0.0003
763 WHITE BLOOD CELL COUNT INCREASED 11 0.0003
764 RASH MACULAR 10 0.0003
765 FLUSHING 29 0.0003
766 NEPHROLITHIASIS 13 0.0003
767 ACUTE RESPIRATORY DISTRESS SYNDROME 5 0.0003
768 MULTIPLE ORGAN DYSFUNCTION SYNDROME 8 0.0003
769 DRUG ERUPTION 5 0.0003
770 HYPOKALAEMIA 13 0.0003
771 IMPAIRED WORK ABILITY 6 0.0003
772 AGEUSIA 7 0.0003
773 THIRST 5 0.0003
774 RASH PRURITIC 15 0.0003
775 HYPOKINESIA 4 0.0003
776 RASH 120 0.0003
777 CRYING 10 0.0003
778 ALOPECIA 54 0.0003
779 INTERVERTEBRAL DISC PROTRUSION 6 0.0003
780 BONE DISORDER 5 0.0003
781 DYSPHONIA 16 0.0003
782 CHILLS 32 0.0003
783 ACCIDENTAL EXPOSURE TO PRODUCT 28 0.0003
784 DENTAL CARIES 3 0.0003
785 BURNING SENSATION 19 0.0003
786 HAEMATOMA 7 0.0003
787 TOOTH DISORDER 6 0.0003
788 AGRANULOCYTOSIS 5 0.0003
789 BACTERIAL INFECTION 5 0.0003
790 MIDDLE INSOMNIA 5 0.0003
791 MUCOSAL INFLAMMATION 7 0.0003
792 JOINT STIFFNESS 7 0.0003
793 GASTRITIS 7 0.0003
794 ARTHRALGIA 110 0.0003
795 FLATULENCE 15 0.0003
796 ECONOMIC PROBLEM 4 0.0003
797 FOOT FRACTURE 5 0.0003
798 RENAL FAILURE 35 0.0003
799 INTERNAL HAEMORRHAGE 3 0.0003
800 GASTRIC DISORDER 9 0.0003
801 SUICIDAL IDEATION 24 0.0003
802 SWELLING FACE 17 0.0003
803 JAUNDICE 7 0.0003
804 EMOTIONAL DISORDER 8 0.0003
805 ANKLE FRACTURE 4 0.0003
806 TENDONITIS 4 0.0003
807 EYELID OEDEMA 3 0.0003
808 CAESAREAN SECTION 3 0.0003
809 ACUTE MYELOID LEUKAEMIA 4 0.0003
810 ORAL HERPES 5 0.0003
811 ILLNESS 26 0.0003
812 PRODUCT PRESCRIBING ERROR 6 0.0003
813 HYPERLIPIDAEMIA 3 0.0003
814 SPINAL FRACTURE 5 0.0002
815 MOVEMENT DISORDER 8 0.0002
816 DRUG DEPENDENCE 40 0.0002
817 INTERSTITIAL LUNG DISEASE 12 0.0002
818 ADRENAL INSUFFICIENCY 3 0.0002
819 PLEURAL EFFUSION 15 0.0002
820 DEPRESSED MOOD 13 0.0002
821 HYPERSOMNIA 7 0.0002
822 BLOOD GLUCOSE INCREASED 46 0.0002
823 METASTASES TO BONE 4 0.0002
824 RIB FRACTURE 5 0.0002
825 VENTRICULAR TACHYCARDIA 4 0.0002
826 URINARY RETENTION 8 0.0002
827 MOUTH ULCERATION 5 0.0002
828 LABORATORY TEST ABNORMAL 7 0.0002
829 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 8 0.0002
830 HEMIPARESIS 4 0.0002
831 RENAL INJURY 7 0.0002
832 HYPOPHAGIA 6 0.0002
833 SCAR 4 0.0002
834 ERYTHEMA 48 0.0002
835 APHASIA 7 0.0002
836 RASH GENERALISED 6 0.0002
837 HYPONATRAEMIA 13 0.0002
838 WHITE BLOOD CELL COUNT DECREASED 25 0.0002
839 BLOOD CREATININE INCREASED 15 0.0002
840 LOCAL SWELLING 4 0.0002
841 PRODUCT QUALITY ISSUE 31 0.0002
842 LIMB DISCOMFORT 7 0.0002
843 EYE HAEMORRHAGE 3 0.0002
844 NERVOUS SYSTEM DISORDER 7 0.0002
845 CARDIAC FAILURE 18 0.0002
846 OFF LABEL USE 194 0.0002
847 PAIN 134 0.0002
848 HAEMATOCHEZIA 12 0.0002
849 ABNORMAL DREAMS 6 0.0002
850 URINARY TRACT INFECTION 37 0.0002
851 DIVERTICULITIS 6 0.0002
852 HUNGER 3 0.0002
853 PAIN IN EXTREMITY 63 0.0002
854 CHOLELITHIASIS 7 0.0002
855 DEVICE OCCLUSION 3 0.0002
856 VISUAL IMPAIRMENT 26 0.0002
857 CARDIOGENIC SHOCK 3 0.0002
858 WEIGHT DECREASED 58 0.0002
859 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 42 0.0002
860 LOCALISED INFECTION 5 0.0002
861 INCORRECT DOSE ADMINISTERED 47 0.0002
862 GASTROENTERITIS 3 0.0002
863 HAEMORRHOIDS 4 0.0002
864 PLASMA CELL MYELOMA 8 0.0002
865 CHOKING 4 0.0002
866 ANAEMIA 39 0.0002
867 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
868 HAEMATOCRIT DECREASED 4 0.0002
869 UPPER LIMB FRACTURE 4 0.0002
870 LACRIMATION INCREASED 6 0.0002
871 FULL BLOOD COUNT DECREASED 4 0.0002
872 DEVICE RELATED INFECTION 3 0.0002
873 DRUG WITHDRAWAL SYNDROME 17 0.0002
874 LUNG INFECTION 3 0.0002
875 EJECTION FRACTION DECREASED 3 0.0002
876 BASAL CELL CARCINOMA 3 0.0002
877 DYSPHAGIA 18 0.0002
878 RENAL FAILURE ACUTE 8 0.0002
879 ABSCESS 3 0.0002
880 CARDIAC FAILURE CONGESTIVE 15 0.0002
881 DISEASE PROGRESSION 22 0.0002
882 FEAR 5 0.0002
883 HOT FLUSH 14 0.0002
884 BLOOD BILIRUBIN INCREASED 5 0.0002
885 BACK PAIN 43 0.0002
886 HAEMOGLOBIN DECREASED 19 0.0002
887 PRURITUS GENERALISED 4 0.0002
888 BLOOD POTASSIUM INCREASED 3 0.0002
889 COLITIS 7 0.0002
890 FOETAL EXPOSURE DURING PREGNANCY 15 0.0002
891 PRODUCT PRESCRIBING ISSUE 4 0.0002
892 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
893 ANGIOEDEMA 8 0.0002
894 FUNGAL INFECTION 6 0.0002
895 GASTROINTESTINAL HAEMORRHAGE 15 0.0002
896 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
897 PAIN IN JAW 5 0.0002
898 DYSGEUSIA 13 0.0002
899 ADVERSE EVENT 16 0.0002
900 SURGERY 10 0.0002
901 PANCREATITIS 9 0.0002
902 THROMBOCYTOPENIA 19 0.0002
903 LYMPHOCYTE COUNT DECREASED 3 0.0002
904 NEUTROPENIA 23 0.0002
905 PLATELET COUNT DECREASED 18 0.0002
906 PRODUCT DOSE OMISSION 11 0.0002
907 MALIGNANT NEOPLASM PROGRESSION 17 0.0002
908 DRUG EFFECT INCOMPLETE 6 0.0002
909 CEREBRAL INFARCTION 4 0.0002
910 ABASIA 4 0.0002
911 BLOOD URINE PRESENT 3 0.0002
912 HAEMATEMESIS 4 0.0002
913 ERECTILE DYSFUNCTION 4 0.0002
914 GLAUCOMA 3 0.0002
915 HIP FRACTURE 5 0.0002
916 SKIN ULCER 4 0.0002
917 SKIN BURNING SENSATION 11 0.0002
918 KIDNEY INFECTION 3 0.0002
919 STAPHYLOCOCCAL INFECTION 5 0.0002
920 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
921 VISUAL ACUITY REDUCED 5 0.0002
922 SKIN DISORDER 5 0.0001
923 COGNITIVE DISORDER 7 0.0001
924 EYE PRURITUS 5 0.0001
925 ANGER 5 0.0001
926 OCULAR HYPERAEMIA 7 0.0001
927 NEUROPATHY PERIPHERAL 14 0.0001
928 DERMATITIS 3 0.0001
929 DEMENTIA 4 0.0001
930 HEART RATE DECREASED 5 0.0001
931 MYALGIA 24 0.0001
932 EMOTIONAL DISTRESS 17 0.0001
933 DRY EYE 7 0.0001
934 RED BLOOD CELL COUNT DECREASED 4 0.0001
935 ARTHRITIS 11 0.0001
936 CEREBRAL HAEMORRHAGE 5 0.0001
937 RECTAL HAEMORRHAGE 6 0.0001
938 HERPES ZOSTER 8 0.0001
939 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
940 WRONG TECHNIQUE IN DRUG USAGE PROCESS 5 0.0001
941 LIVER FUNCTION TEST ABNORMAL 4 0.0001
942 PULMONARY EMBOLISM 13 0.0001
943 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
944 COLITIS ULCERATIVE 6 0.0001
945 INFLUENZA LIKE ILLNESS 11 0.0001
946 INTESTINAL OBSTRUCTION 5 0.0001
947 FEMUR FRACTURE 4 0.0001
948 RASH ERYTHEMATOUS 6 0.0001
949 BLOOD PRESSURE FLUCTUATION 3 0.0001
950 DEEP VEIN THROMBOSIS 8 0.0001
951 PSORIASIS 16 0.0001
952 LUNG NEOPLASM MALIGNANT 5 0.0001
953 SKIN EXFOLIATION 10 0.0001
954 THERAPY CESSATION 6 0.0001
955 HAEMATURIA 4 0.0001
956 DRUG RESISTANCE 3 0.0001
957 THERAPY INTERRUPTED 8 0.0001
958 LIMB INJURY 3 0.0001
959 SKIN DISCOLOURATION 5 0.0001
960 RENAL DISORDER 5 0.0001
961 CARDIAC DISORDER 10 0.0001
962 EYE PAIN 6 0.0001
963 HAEMORRHAGE 11 0.0001
964 DIABETES MELLITUS 8 0.0001
965 EYE IRRITATION 6 0.0001
966 BLOOD GLUCOSE DECREASED 5 0.0001
967 ACUTE MYOCARDIAL INFARCTION 3 0.0001
968 LEUKOPENIA 5 0.0001
969 HOSPITALISATION 15 0.0001
970 RENAL IMPAIRMENT 8 0.0001
971 CYSTITIS 3 0.0001
972 MOOD SWINGS 3 0.0001
973 HYPOACUSIS 4 0.0001
974 DEVICE USE ERROR 3 0.0001
975 BONE PAIN 5 0.0001
976 LYMPHADENOPATHY 3 0.0001
977 CATARACT 5 0.0001
978 MULTIPLE SCLEROSIS 4 0.0001
979 CEREBROVASCULAR ACCIDENT 14 0.0001
980 PRODUCT DOSE OMISSION ISSUE 24 0.0001
981 MYOCARDIAL INFARCTION 13 0.0001
982 BLINDNESS 3 0.0001
983 DEPENDENCE 4 0.0001
984 DEVICE MALFUNCTION 5 0.0001
985 ACNE 5 0.0001
986 THROMBOSIS 5 0.0001
987 INJECTION SITE ERYTHEMA 7 0.0001
988 INJECTION SITE SWELLING 4 0.0001
989 INJECTION SITE PAIN 14 0.0000
990 DEVICE ISSUE 4 0.0000
991 DRY SKIN 5 0.0000
992 DRUG DOSE OMISSION 6 0.0000